{
  "trial_id": "NCT01901146",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, histological type of breast cancer, tumor size, HER2 status, estrogen receptor (ER) status, progesterone receptor (PR) status, bone marrow function, hepatic function, renal function, left ventricular ejection fraction (LVEF), prior chemotherapy cycles, presence of metastases, history of other malignancies, peripheral neuropathy status, cardiovascular health, respiratory health, infection history, pregnancy status, breastfeeding status, contraceptive use, participation in other investigational studies, sensitivity to study drugs, availability for study visits, other significant medical conditions.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Axilla Lymph Node Involvement",
          "tumor size"
        ],
        [
          "Hormone Receptor Status",
          "estrogen receptor (ER) status"
        ],
        [
          "Hormone Receptor Status",
          "progesterone receptor (PR) status"
        ],
        [
          "Paclitaxel Dosing Schedule",
          "prior chemotherapy cycles"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Tumor Stage",
        "Geographic Region"
      ],
      "remaining_candidate_features": [
        "histological type of breast cancer",
        "HER2 status",
        "bone marrow function",
        "hepatic function",
        "renal function",
        "left ventricular ejection fraction (LVEF)",
        "presence of metastases",
        "history of other malignancies",
        "peripheral neuropathy status",
        "cardiovascular health",
        "respiratory health",
        "infection history",
        "pregnancy status",
        "breastfeeding status",
        "contraceptive use",
        "participation in other investigational studies",
        "sensitivity to study drugs",
        "availability for study visits",
        "other significant medical conditions"
      ]
    },
    "processed-gen-response": "Age, sex, histological type of breast cancer, tumor size, HER2 status, estrogen receptor (ER) status, progesterone receptor (PR) status, bone marrow function, hepatic function, renal function, left ventricular ejection fraction (LVEF), prior chemotherapy cycles, presence of metastases, history of other malignancies, peripheral neuropathy status, cardiovascular health, respiratory health, infection history, pregnancy status, breastfeeding status, contraceptive use, participation in other investigational studies, sensitivity to study drugs, availability for study visits, other significant medical conditions."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Estrogen Receptor (ER) Status, Progesterone Receptor (PR) Status, HER2 Status, Tumor Size, Lymph Node Status, Left Ventricular Ejection Fraction (LVEF), Baseline Hematologic Parameters, Baseline Hepatic Function, Baseline Renal Function,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Hormone Receptor Status",
          "Estrogen Receptor (ER) Status"
        ],
        [
          "Axilla Lymph Node Involvement",
          "Lymph Node Status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Tumor Stage",
        "Paclitaxel Dosing Schedule",
        "Geographic Region"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Progesterone Receptor (PR) Status",
        "HER2 Status",
        "Tumor Size",
        "Left Ventricular Ejection Fraction (LVEF)",
        "Baseline Hematologic Parameters",
        "Baseline Hepatic Function",
        "Baseline Renal Function"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, Estrogen Receptor (ER) Status, Progesterone Receptor (PR) Status, HER2 Status, Tumor Size, Lymph Node Status, Left Ventricular Ejection Fraction (LVEF), Baseline Hematologic Parameters, Baseline Hepatic Function, Baseline Renal Function"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Region of Enrollment, Body Mass Index, Menopausal Status, Estrogen Receptor Status, Progesterone Receptor Status, HER2 Status, Tumor Size, Lymph Node Status, Left Ventricular Ejection Fraction.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Hormone Receptor Status",
          "Estrogen Receptor Status"
        ],
        [
          "Hormone Receptor Status",
          "Progesterone Receptor Status"
        ],
        [
          "Axilla Lymph Node Involvement",
          "Lymph Node Status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Tumor Stage",
        "Paclitaxel Dosing Schedule",
        "Geographic Region"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Body Mass Index",
        "Menopausal Status",
        "HER2 Status",
        "Tumor Size",
        "Left Ventricular Ejection Fraction"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Region of Enrollment, Body Mass Index, Menopausal Status, Estrogen Receptor Status, Progesterone Receptor Status, HER2 Status, Tumor Size, Lymph Node Status, Left Ventricular Ejection Fraction."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), HER2 status, estrogen receptor (ER) status, progesterone receptor (PR) status, tumor size, tumor grade, nodal status, left ventricular ejection fraction (LVEF), performance status, menopausal status, prior breast cancer history, family history of breast cancer.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Hormone Receptor Status",
          "estrogen receptor (ER) status"
        ],
        [
          "Axilla Lymph Node Involvement",
          "nodal status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Tumor Stage",
        "Paclitaxel Dosing Schedule",
        "Geographic Region"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "body mass index (BMI)",
        "HER2 status",
        "progesterone receptor (PR) status",
        "tumor size",
        "tumor grade",
        "left ventricular ejection fraction (LVEF)",
        "performance status",
        "menopausal status",
        "prior breast cancer history",
        "family history of breast cancer"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), HER2 status, estrogen receptor (ER) status, progesterone receptor (PR) status, tumor size, tumor grade, nodal status, left ventricular ejection fraction (LVEF), performance status, menopausal status, prior breast cancer history, family history of breast cancer."
  }
}